Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure

In children with gastrointestinal disorders such as inflammatory bowel disease (IBD) and intestinal failure (IF), the risk of venous thromboembolism (VTE) is increased. VTE may lead to pulmonary embolism, sepsis and central line infection, stroke and post-thrombotic syndrome. The purpose of this rev...

Full description

Bibliographic Details
Main Authors: Renz C. W. Klomberg, Lotte E. Vlug, Barbara A. E. de Koning, Lissy de Ridder
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.885876/full
_version_ 1818541358068006912
author Renz C. W. Klomberg
Lotte E. Vlug
Barbara A. E. de Koning
Lissy de Ridder
author_facet Renz C. W. Klomberg
Lotte E. Vlug
Barbara A. E. de Koning
Lissy de Ridder
author_sort Renz C. W. Klomberg
collection DOAJ
description In children with gastrointestinal disorders such as inflammatory bowel disease (IBD) and intestinal failure (IF), the risk of venous thromboembolism (VTE) is increased. VTE may lead to pulmonary embolism, sepsis and central line infection, stroke and post-thrombotic syndrome. The purpose of this review is to summarize current knowledge and recent advances around VTE management in pediatric gastroenterology with a focus on IBD and IF. The VTE incidence in children with IBD is reported to be around 4–30 per 10,000 patient-years, with higher incidences for hospitalized children. While in general, IF is less common than IBD, the VTE incidence in children with IF is around 750 per 10,000 patient-years. The most common risk factors for development of VTE involve deviations leading to Virchow's triad (endothelial damage, stasis, and hypercoagulability) and include active inflammation, particularly with colonic involvement, presence of a central venous catheter, underlying thrombophilia, reduced mobility, surgery, and hospitalization. Classes of anticoagulants used for treatment of VTE are low molecular weight heparins and vitamin K antagonists. However, the use of direct oral anticoagulants for treatment or prevention of VTE has not been studied in this pediatric population yet. Pediatric gastroenterologists apply different VTE prevention and treatment strategies due to lack of literature and lack of consensus. We discuss the role of primary and secondary prophylactic use of anticoagulants, and provide tools and recommendations for screening, prevention and management for the specific pediatric populations.
first_indexed 2024-12-11T22:08:14Z
format Article
id doaj.art-29b1dcb4b8fa418885223c34d2693230
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-11T22:08:14Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-29b1dcb4b8fa418885223c34d26932302022-12-22T00:48:53ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602022-04-011010.3389/fped.2022.885876885876Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal FailureRenz C. W. KlombergLotte E. VlugBarbara A. E. de KoningLissy de RidderIn children with gastrointestinal disorders such as inflammatory bowel disease (IBD) and intestinal failure (IF), the risk of venous thromboembolism (VTE) is increased. VTE may lead to pulmonary embolism, sepsis and central line infection, stroke and post-thrombotic syndrome. The purpose of this review is to summarize current knowledge and recent advances around VTE management in pediatric gastroenterology with a focus on IBD and IF. The VTE incidence in children with IBD is reported to be around 4–30 per 10,000 patient-years, with higher incidences for hospitalized children. While in general, IF is less common than IBD, the VTE incidence in children with IF is around 750 per 10,000 patient-years. The most common risk factors for development of VTE involve deviations leading to Virchow's triad (endothelial damage, stasis, and hypercoagulability) and include active inflammation, particularly with colonic involvement, presence of a central venous catheter, underlying thrombophilia, reduced mobility, surgery, and hospitalization. Classes of anticoagulants used for treatment of VTE are low molecular weight heparins and vitamin K antagonists. However, the use of direct oral anticoagulants for treatment or prevention of VTE has not been studied in this pediatric population yet. Pediatric gastroenterologists apply different VTE prevention and treatment strategies due to lack of literature and lack of consensus. We discuss the role of primary and secondary prophylactic use of anticoagulants, and provide tools and recommendations for screening, prevention and management for the specific pediatric populations.https://www.frontiersin.org/articles/10.3389/fped.2022.885876/fullthrombosisCrohn's diseaseulcerative colitisshort bowel syndromethromboprophylaxisanticoagulation
spellingShingle Renz C. W. Klomberg
Lotte E. Vlug
Barbara A. E. de Koning
Lissy de Ridder
Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure
Frontiers in Pediatrics
thrombosis
Crohn's disease
ulcerative colitis
short bowel syndrome
thromboprophylaxis
anticoagulation
title Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure
title_full Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure
title_fullStr Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure
title_full_unstemmed Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure
title_short Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure
title_sort venous thromboembolic complications in pediatric gastrointestinal diseases inflammatory bowel disease and intestinal failure
topic thrombosis
Crohn's disease
ulcerative colitis
short bowel syndrome
thromboprophylaxis
anticoagulation
url https://www.frontiersin.org/articles/10.3389/fped.2022.885876/full
work_keys_str_mv AT renzcwklomberg venousthromboemboliccomplicationsinpediatricgastrointestinaldiseasesinflammatoryboweldiseaseandintestinalfailure
AT lotteevlug venousthromboemboliccomplicationsinpediatricgastrointestinaldiseasesinflammatoryboweldiseaseandintestinalfailure
AT barbaraaedekoning venousthromboemboliccomplicationsinpediatricgastrointestinaldiseasesinflammatoryboweldiseaseandintestinalfailure
AT lissyderidder venousthromboemboliccomplicationsinpediatricgastrointestinaldiseasesinflammatoryboweldiseaseandintestinalfailure